Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Cancer Survivorship: longer term issues and the role of primary care - Prof Eila Watson (Oxford Brookes University).
Don't miss our upcoming webinars! Subscribe today!
In April, CCSN virtually met with MPPs throughout Ontario to discuss our COVID-19 and Cancer Care - Wave 2 Survey. During these meetings, we discussed the difficulty cancer patients and pre-diagnosis patients have had with accessing cancer services during the pandemic and the importance of ensuring the cancer patients receive their 1st and 2nd vaccine doses in a timely manner.
In this webinar, CCSN's Public Policy Analyst Conrad will begin by sharing some of the highlights from our meetings with Ontario MPPs. He will then turn things over to our patient advocates and they will share some of their reflections from our meetings as well as their own experiences with accessing cancer care during the pandemic. Lastly, Conrad will take a closer look at the Ontario data from our survey.
View the YouTube video: https://youtu.be/05u4i89WFfQ
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar:
Join Alies, a patient partner, and Ambreen, a patient-oriented researcher, as they explore ways to listen and learn from seldom heard patient populations. Both speakers share their experiences in the world of patient engagement, discuss the need to include patient-identified priorities in the delivery of healthcare and reflect on the current structure of patient partnerships which can be exclusionary. As a way forward, Alies and Ambreen introduce Equity-Mobilizing Partnerships in Community (EMPaCT) as an approach which strives to centre diverse patient voices, create a culture of listening and learning from the experiences of patient partners and develop a learning healthcare system ecosystem which is responsive to the needs of all patients in order to improve health outcomes, in particular health equity.
View the YouTube video: https://youtu.be/Yx762mVjML8
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...Cancer Institute NSW
Patients with Squamous cell carcinoma (SCC) of the Head and Neck (H&N) are often treated with curative intent using treatment protocols placing them at high risk of nutritional decline. Recently released COSA guidelines recommend that prophylactic enteral feeding should be considered for T4 upper aerodigestive tract tumours undergoing concurrent chemoradiotherapy. Evidence is yet to identify optimal method of nutrition intervention and timing across all tumour stages in this population.
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Cancer Survivorship: longer term issues and the role of primary care - Prof Eila Watson (Oxford Brookes University).
Don't miss our upcoming webinars! Subscribe today!
In April, CCSN virtually met with MPPs throughout Ontario to discuss our COVID-19 and Cancer Care - Wave 2 Survey. During these meetings, we discussed the difficulty cancer patients and pre-diagnosis patients have had with accessing cancer services during the pandemic and the importance of ensuring the cancer patients receive their 1st and 2nd vaccine doses in a timely manner.
In this webinar, CCSN's Public Policy Analyst Conrad will begin by sharing some of the highlights from our meetings with Ontario MPPs. He will then turn things over to our patient advocates and they will share some of their reflections from our meetings as well as their own experiences with accessing cancer care during the pandemic. Lastly, Conrad will take a closer look at the Ontario data from our survey.
View the YouTube video: https://youtu.be/05u4i89WFfQ
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar:
Join Alies, a patient partner, and Ambreen, a patient-oriented researcher, as they explore ways to listen and learn from seldom heard patient populations. Both speakers share their experiences in the world of patient engagement, discuss the need to include patient-identified priorities in the delivery of healthcare and reflect on the current structure of patient partnerships which can be exclusionary. As a way forward, Alies and Ambreen introduce Equity-Mobilizing Partnerships in Community (EMPaCT) as an approach which strives to centre diverse patient voices, create a culture of listening and learning from the experiences of patient partners and develop a learning healthcare system ecosystem which is responsive to the needs of all patients in order to improve health outcomes, in particular health equity.
View the YouTube video: https://youtu.be/Yx762mVjML8
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...Cancer Institute NSW
Patients with Squamous cell carcinoma (SCC) of the Head and Neck (H&N) are often treated with curative intent using treatment protocols placing them at high risk of nutritional decline. Recently released COSA guidelines recommend that prophylactic enteral feeding should be considered for T4 upper aerodigestive tract tumours undergoing concurrent chemoradiotherapy. Evidence is yet to identify optimal method of nutrition intervention and timing across all tumour stages in this population.
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershmanbkling
Dr. Dawn L. Hershman of the Herbert Irving Comprehensive Cancer Center at Columbia University presented the basics of clinical trials and emphasized how important it is for more patients to participate in them. She also discussed trials currently available for early stage and metastatic breast cancers. The webinar was presented on June 25, 2014. To hear the webinar, visit www.sharecancersupport.org/hershman
Don't miss our upcoming webinars. Subscribe today!
In this webinar:
Attendees will learn about the role of exercise in the cancer care pathway, and the potential benefits from building a habit of moving more. We will also discuss the EXCEL study: EXercise for Cancer to Enhance Living Well, and how it is providing a sustainable exercise and behaviour change program to those living with cancer in rural and remote regions across Canada. Learn what is involved in this exercise research program and how to get involved online now!
View the YouTube video: https://youtu.be/BIOviCzESwA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
This keynote speech was delivered by Janet Freeman-Daily to the IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology on September 14, 2017.
Existing value frameworks for cancer care omit a key component: patient-defined value. This presentation looks at some patient perspectives on value found in patient-driven research, discusses the importance of shared decision making and goals of care discussions, and shares resources to help clinicians incorporate patient-defined value in cancer care.
Survivorship Care Plans in the U.S.: Current Status and Future ChallengesCarevive
On Q Health's Chief Clinical Officer, Dr. Carrie Tompkins Stricker, gave a presentation on survivorship care plans in Tokyo, Japan during the 1st International Seminar on Cancer Nursing. The seminar theme was "The Role of Cancer Nursing in Improving Quality of Cancer Care: The Current Situation and Outlook for Developments 10 Years from Now".
Learn more about survivorship and On Q Health's Care Planning System™: http://bit.ly/onqcareplans
Cancer Survivorship and the Role of an APPflasco_org
Providing a course that is relevant, practical and patient-centered that will positively impact the speed in which entry-level oncology specialists integrate into the oncology practice setting.
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
Insights will be provided by a panel of representatives from other chronic disease patient advocacy organizations who will discuss how they interact with health systems, successfully advocate, and help each other through the ongoing journey of dealing with a chronic illness.
Contact the presenters:
●
●
●
View the video: https://youtu.be/QIQKAUmuEJA
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
One in five women who survive breast cancer will develop lymphoedema of the upper body at some point in their life. Following breast surgery, women are recommended to follow strategies to minimise their lymphoedema risk (e.g., limiting exposure of the at-risk arm to trauma). Adherence to these strategies is typically less than optimal.
Providing coordinated cancer care: a population-based survey of patients' exp...Cancer Institute NSW
Improving cancer care coordination is a key priority for health services. Understanding the patient experience and who is at risk of receiving poorly coordinated care is crucial to underpin service improvement. However, there is little understanding of the adequacy of care coordination within Australia.
Don't miss our upcoming webinars! Subscribe today.
In this webinar:
Our presenters will talk about the work the LAO does, provide information about the causes and symptoms of lymphedema, and inform lymphedema patients on how to access help and support. They will also include the physiotherapist perspective and discuss what treatments are available.
View the YouTube video: https://youtu.be/Wg1dzEOBPEA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
This presentation will highlight the promising new therapeutic strategies in the treatment of gliomas, with a focus on trials or therapies that will soon be available for Canadian patients.
View the YouTube video: https://youtu.be/ibbEuvSF7xY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...bkling
Current and former clinical trial participants discuss decision-making from a patient's perspective. What factors should you consider when choosing a clinical trial? What are the potential benefits of participating? What misconceptions might discourage people from seeking clinical trials? When is it best not to participate? Panelists include women living with metastatic breast and ovarian cancers.
Program Manager, Gastroenterologist at Associates in Gastroenterology in Rockville Maryland & the American College of Gastroenterology (ACG) Governor for Maryland
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershmanbkling
Dr. Dawn L. Hershman of the Herbert Irving Comprehensive Cancer Center at Columbia University presented the basics of clinical trials and emphasized how important it is for more patients to participate in them. She also discussed trials currently available for early stage and metastatic breast cancers. The webinar was presented on June 25, 2014. To hear the webinar, visit www.sharecancersupport.org/hershman
Don't miss our upcoming webinars. Subscribe today!
In this webinar:
Attendees will learn about the role of exercise in the cancer care pathway, and the potential benefits from building a habit of moving more. We will also discuss the EXCEL study: EXercise for Cancer to Enhance Living Well, and how it is providing a sustainable exercise and behaviour change program to those living with cancer in rural and remote regions across Canada. Learn what is involved in this exercise research program and how to get involved online now!
View the YouTube video: https://youtu.be/BIOviCzESwA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
This keynote speech was delivered by Janet Freeman-Daily to the IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology on September 14, 2017.
Existing value frameworks for cancer care omit a key component: patient-defined value. This presentation looks at some patient perspectives on value found in patient-driven research, discusses the importance of shared decision making and goals of care discussions, and shares resources to help clinicians incorporate patient-defined value in cancer care.
Survivorship Care Plans in the U.S.: Current Status and Future ChallengesCarevive
On Q Health's Chief Clinical Officer, Dr. Carrie Tompkins Stricker, gave a presentation on survivorship care plans in Tokyo, Japan during the 1st International Seminar on Cancer Nursing. The seminar theme was "The Role of Cancer Nursing in Improving Quality of Cancer Care: The Current Situation and Outlook for Developments 10 Years from Now".
Learn more about survivorship and On Q Health's Care Planning System™: http://bit.ly/onqcareplans
Cancer Survivorship and the Role of an APPflasco_org
Providing a course that is relevant, practical and patient-centered that will positively impact the speed in which entry-level oncology specialists integrate into the oncology practice setting.
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
Insights will be provided by a panel of representatives from other chronic disease patient advocacy organizations who will discuss how they interact with health systems, successfully advocate, and help each other through the ongoing journey of dealing with a chronic illness.
Contact the presenters:
●
●
●
View the video: https://youtu.be/QIQKAUmuEJA
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
One in five women who survive breast cancer will develop lymphoedema of the upper body at some point in their life. Following breast surgery, women are recommended to follow strategies to minimise their lymphoedema risk (e.g., limiting exposure of the at-risk arm to trauma). Adherence to these strategies is typically less than optimal.
Providing coordinated cancer care: a population-based survey of patients' exp...Cancer Institute NSW
Improving cancer care coordination is a key priority for health services. Understanding the patient experience and who is at risk of receiving poorly coordinated care is crucial to underpin service improvement. However, there is little understanding of the adequacy of care coordination within Australia.
Don't miss our upcoming webinars! Subscribe today.
In this webinar:
Our presenters will talk about the work the LAO does, provide information about the causes and symptoms of lymphedema, and inform lymphedema patients on how to access help and support. They will also include the physiotherapist perspective and discuss what treatments are available.
View the YouTube video: https://youtu.be/Wg1dzEOBPEA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
This presentation will highlight the promising new therapeutic strategies in the treatment of gliomas, with a focus on trials or therapies that will soon be available for Canadian patients.
View the YouTube video: https://youtu.be/ibbEuvSF7xY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...bkling
Current and former clinical trial participants discuss decision-making from a patient's perspective. What factors should you consider when choosing a clinical trial? What are the potential benefits of participating? What misconceptions might discourage people from seeking clinical trials? When is it best not to participate? Panelists include women living with metastatic breast and ovarian cancers.
Program Manager, Gastroenterologist at Associates in Gastroenterology in Rockville Maryland & the American College of Gastroenterology (ACG) Governor for Maryland
Ms. Hall is the former Vice President of Operations for Carena, a health care delivery company. Prior to joining Carena, Hall spent nearly 18 years with the Microsoft Corporation.
Jeffrey A. Meyerhardt, MD, MPH
Associate Professor of Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute - speaker for Tuesday Call-on Congress 2012
Two new drugs for colorectal cancer may offer new hope for late stage patients, and they might hit the market in 2013.
Dr. Rich Goldberg, physician-in-chief of the Ohio State University Medical Center and a leader in colorectal cancer research is going to give you the straight facts about these drugs:
* What hope might they offer?
* What side effects do they cause?
* Will either be the right drug for you?
About Dr. Goldberg:
Dr. Richard Goldberg is an internationally renowned gastrointestinal oncologist and the physician-in-chief at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Institute (OSUCCC-James). He is a member and former chair of the National Cancer Institute Colorectal Task Force and an international leader in evaluating new agents for the treatment of colorectal cancer and researching inherited colorectal cancer syndromes
Dr. Brian Lawenda provided us this terrific presentation on integrative approaches to preventing and treating cancer. Dr. Lawenda is a Harvard trained radiation oncologist working in las Vegas for 21st Century Oncology. It certainly helps to have him lecture along with this presentation because this can be a complicated discussion.
Many complementary therapies, used along with conventional medicine, can support cancer treatments, reduce some of the adverse effects of cancer treatment, ease tension and pain, and contribute to overall health. This is known as integrative medicine. Integrative medicine can be a part of your plan throughout the entire treatment and survivorship experience. In this webinar, we will talk about how integration can be helpful to you after a colorectal cancer diagnosis and your journey forward.
Presented by Dr. Lisa Corbin: a board-certified internist, Associate Professor in the Department of Internal Medicine at the University of Colorado School of Medicine. In 2001, she helped the University of Colorado Hospital establish the Center for Integrative Medicine (TCFIM) and has served as the Medical Director ever since.
How can front-line professionals incorporate the emerging brain health ...SharpBrains
(Session held at the 2014 SharpBrains Virtual Summit; October 28-30th, 2014)
12:30-2pm. How can front-line professionals incorporate the emerging brain health toolkit to their practices?
- Elizabeth Frates, Director of Medical Student Education at the Institute of Lifestyle Medicine
- Dr. Catherine Madison, Director of the Ray Dolby Brain Health Center at California Pacific Medical Center
- Barbara Van Amburg, Chief Nursing Officer at Kaiser Permanente Redwood City
- Dr. Wendy Law, Clinical Neuropsychologist at Walter Reed National Military Medical Center
- Chair: Dr. Michael O’Donnell, Editor-In-Chief of the American Journal of Health Promotion
Learn more here:
http://sharpbrains.com/summit-2014/agenda/
When is it time for a new cancer treatment, and how should patients make these difficult decisions? Rachel Yung, MD, provides an overview of what to consider when making difficult treatment choices.
How to Transition from Allopathic to Integrated Practice - IMM Brazil 2015Louis Cady, MD
In this lecture, Dr. Cady compares and contrasts the significance differences, both conceptually and practically, between the conventional practice of medicine and a more rational, functional, integrated approach. Tactical concepts and didactic tools to make the transition are reviewed.
Hospice care and palliative care: Is there a difference between the two, and if so, what?
Many people still think that palliative care means hospice care. But today, hospice is only a small part of palliative care.
The goal of palliative care is to prevent or treat the symptoms and side effects of a disease; and it should be part of the picture from the first day a serious illness is diagnosed.
Dr. Jim Meadows, Director of Hospice and Palliative Care at Tennessee Oncology, will discuss this important topic. How does a family and a health care team best work together to guide a patient through a terminal illness? How does everyone continue to support quality, patient-centered, end-of-life care?
I didn't know this option of Palliative care existed prior to my mother's passing earlier this year of colorectal cancer. However, I do now know about it and want to share it with all of you
Presentation on palliative care given at the Caregiver's Conference for the Cystic Fibrosis Affiliate and Satellite Sites at Riley Children's Hospital.
Dr. Murphy presents slides discussing general screening trends in the US, including how the US compares to other countries, different screening modalities, and differences in screening by:
-Age
-Gender
-Geography
-Race/Ethnicity
Looking to kick start your physical activity? Hoping to learn about how body movement can be a huge benefit for CRC patients and survivors? Curious about Climb for a Cure? Join this interactive webinar featuring Karia Coleman, MSK, personal trainer and athletic strength coach, and Fight CRC advocates as they discuss the importance, challenges, and joys of physical activity.
From bowel frequency, pain, and more, many colorectal cancer treatments lead to digestive side effects. Join this webinar with Dr. Cathy Eng to learn all about the digestive system, the side effects that are common due to CRC treatment, and how to manage those side effects.
Maine recently passed major colorectal cancer (CRC) policy at the state level. Join us to listen to their story and learn what worked well for CRC state advocacy!
Indiana just passed major colorectal cancer (CRC) policy this year. Join us to listen to their story and learn what worked well for CRC advocacy in Indiana!
Kentucky was one of the first states in the US to pass major colorectal cancer (CRC) policy. Join us to listen to their story and learn what worked well for CRC state advocacy!
Join Fight CRC in a webinar about biomarkers. In this session, Dr. Chris Lieu will focus the discussion on the NTRK biomarker, in addition to ctDNA, and Next-Generation Sequencing.
Join us as Eden Stotsky-Himelfarb, BSN, RN from Johns Hopkins Medicine discusses how to manage after a colorectal cancer diagnosis. In this session, she will cover understanding diagnoses, shared decision making, managing mental health, talking to family and colleagues, and more.
Some colorectal cancer treatments lead to side effects of the skin. In this webinar, Dr. Nicole LeBoeuf will discuss these specific side effects. She will talk about why they occur, how to prepare for them, and how to manage them.
Hear about the latest breaking colorectal cancer research! Fight CRC will be joined by Dr. Axel Grothey who will spend the hour detailing the research presented at the 2020 Gastrointestinal (GI) Cancers Symposium hosted by the American Society of Clinical Oncology.
Anticipating the end of life and making decisions about medical care at this time can be difficult and distressing for people with cancer and their loved ones. However, it is incredibly important to plan for the transition to end-of-life care.
In this webinar, we will discuss questions to ask when considering an end to curative treatment, what to expect with hospice and end-of-life care, a new medical care team, advance directives and healthcare proxies, options for pain, the role of caregivers and loved ones, and more.
In this webinar, Dr. Angela Nicholas, Dr. Chris Heery, and Wenora Johnson discuss all things clinical trials. Dr. Nicholas, a family practitioner and caregiver to her late husband, John MacCleod will dive into her experience searching for clinical trials along with advice to those currently searching, or planning on searching in the future. Dr. Heery, Chief Medical Officer for Precision Biosciences will spend time dispelling myths around clinical trials and challenges to enrollment, and Wenora Johnson, a stage III colon cancer survivor will describe the process and her point of view curating trials in the Fight CRC trial finder.
In this webinar, Dr. Popp will discuss everything you need to know about palliative care! This is an important webinar for colorectal cancer patients and their loved ones.
eeling worn out and exhausted all the time? You may be experiencing cancer-related fatigue. Tune in to this webinar to learn what cancer-related fatigue is, how to spot it, and how to manage it.
In this webinar, Dr. Azad discusses colorectal cancer recurrence. She addresses things to do to help reduce the risk of recurrence, in addition to what steps should be taken if colon or rectal cancer returns.
Join Fight CRC and Dr. Scott Kopetz to learn about the latest breaking colorectal cancer research from the American Society of Clinical Oncology 2019 Annual Conference.
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarFight Colorectal Cancer
Neuropathy is a common side effect for colorectal cancer patients. It is a side effect that can be incredibly challenging to manage, and can affect daily living. Join this informative webinar to learn all about neuropathy—why it happens, how to prepare for it, and methods to try and reduce its effects. This is an important webinar for all survivors and patients! Dana will speak from both the medical professional and patient angle, as she is a colon cancer survivor herself!
A cancer diagnosis and cancer treatment can be traumatic. An experience with cancer can lead to serious psychological distress that should be addressed. In this webinar, Schuyler Cunningham, Clinical Social Worker, talks about what trauma is, how to identify it, and what steps to take next.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
1. Welcome!
Managing Your Symptoms and
Treatment Side Effects
Part of Fight Colorectal Cancer’s Monthly Patient Webinar Series
Our webinar will begin shortly
www.FightColorectalCancer.org
877-427-2111
2. 1. Tonight’s speaker: Kristen Fessele, RN, MSN, ANP-BC, AOCN
2. Archived webinars: Link.FightCRC.org/Webinars
3. Follow up survey to come via email. Get a free Blue Star of
Hope pin when you tell us how we did tonight
4. Ask a question in the panel on the right side of your screen
5. Or call the Fight Colorectal Cancer Answer Line at
877-427-2111
5. About ONS
• The Oncology Nursing Society is a professional
association of more than 35,000 members
committed to promoting excellence in oncology
nursing and the transformation of cancer care.
• Since 1975, ONS has provided a professional
community for oncology nurses, developed
evidence-based education programs and
treatment information, and advocated for patient
care, all in an effort to improve quality of life and
outcomes for patients with cancer and their
families.
6. ONS Congress 2012
• 37th annual meeting, held in New Orleans,
LA on May 2-6, 2012
• Over 3000 oncology nurses attended to
share knowledge
• Selected topics for tonight:
– Complementary and Alternative Medicine
– Caregiver Issues
– Personalized Medicine
7. Complementary and Alternative
Medicine
• Judith Fouladbakhsh, PhD, APRN, AHN-BC
– Wayne State University, Detroit MI
• Lynda Balneaves, RN, PhD
– UBC School of Nursing, Vancouver BC
• Cecile Lengacher, RN, PhD
– USF College of Nursing, Tampa FL
8. Complementary and Alternative
Medicine
• “… a group of diverse medical and health
care systems, practices, and products that
are not considered to be part of
conventional medicine…”
- National Center for Complementary and
Alternative Medicine (NCCAM)
9. Talk about CAM use with your
oncology team!
• Gain potential benefits
• Keep open lines of communication
between you and your healthcare team
• Avoid safety issues
10. CAM use is widespread
• According to Fouladbakhsh
– Almost 1 in 2 people with cancer use some
form of CAM
• CAM
– Providers
– Practices
– Products
12. Tips to Find a Good
CAM Provider
• Accredited school
• Board certified/licensed
• Ask other professionals you trust for
referrals
• Find a local integrative medicine program
• Willing to talk by phone to establish
rapport
Fouladbakhsh & Stommel, 2007
14. CAM Products
• Vitamins
• Herbs
• Supplements
• Production and claims of effectiveness not
regulated
• Treat like a regular medication
– Risks, benefits and potential to interact with
other medicines
– Just because it’s natural, doesn’t mean it’s
risk-free…
15. Stress Reducing
Complementary Therapies
• What we think affects how our bodies work
– Mind-body connection
• Prolonged stress negatively affects health
• Practices to relieve stress may help
physical and emotional coping with the
cancer experience for patients and
caregivers
16. “Fight or Flight”
Stress Response
• Short term stress is meant to be protective
17. Effect of prolonged stress
• Elevated stress hormones
• Suppressed immunity
• May lead to new or worsening health
issues
– Physical
– Emotional
18. Stress Reduction Practices
• Meditation
• Mindfulness-Based Stress Reduction
• Tai Chi
• Qi Gong
• Yoga
• and more…
19. Caring for Caregivers
• Laurel Northouse, RN, PhD, FAAN
– University of Michigan School of Nursing,
Ann Arbor MI
• Jane Meier Hamilton, MSN, RN
– Partners on the Path, Gwynedd Valley PA
• Joanne Hambleton, RN, MSN, NE-BC
– Fox Chase Cancer Center, Philadelphia PA
20. Many Caregivers in Oncology
• Professionals
– Nurses, Physicians, Social Workers,
Pharmacists, etc.
• Family Caregivers
• Volunteers
21. Each group faces challenges
• Caregiver Stress
• Sleep Deprivation
• Compassion Fatigue
• Burnout
22. Special challenges for the
Family Caregiver
• Caregivers face many demands
• Few resources to learn how to be a
caregiver
• The situation affects both the caregiver
and patient physically and emotionally
23. More attention to come
• Researchers are studying ways to support
family and informal caregivers of people
with cancer
– Best ways to educate, prepare and support
caregivers
– To ease strain and burden
– To promote physical and emotional health in
the caregiver over the course of the patient’s
experience
24. Personalized Healthcare
• “Patient/Person-centered Care”
– Making the patient the focus of the health
care system
– A “Hot Topic” in healthcare reform
• Treatment planning that considers:
– How your body “digests” medicines
– Features about your particular tumor cells that
can guide the best treatment choices
25. How your body
“digests” medicines
• When you take a medicine, your body:
– Changes it into an “active” form before use
– “Metabolizes” it out of your body, often
through the liver or kidneys
• Chemical process
– Some people’s chemicals work at different
rates than others
– Some people lack needed chemicals to
“digest” certain medicines
26. What if I “digest” differently?
• Researchers are interested to study these
digestion/metabolism systems
• Medication choices might change based
on knowledge of how a particular person
metabolizes
– Too fast = might need a higher dose
– Too slow = might need a lower dose, and/or
be careful with other medicines that need to
use the same “digestion” system
– Missing = Choose a different medicine
27.
28.
29. Examples
• Thymidylate Synthase (TS)
– 5-FU works by inhibiting TS
– High TS levels may mean 5-FU doesn’t work
as well
• Dihydropyrimidine Dehydrogenase (DPD)
– Deficiency associated with 5-FU side effects
• UGT1A1
– A polymorphism (normal difference) in this
enzyme may decrease ability to metabolism
irinotecan = increased side effects
30. Treating the Tumor’s
Characteristics
• What’s sticking out of the surface of the
cancer cell?
• What pathways are active between the cell
surface and the nucleus?
• What changes are there in the cancer
cell’s genetic material?
37. UPCOMING WEBINARS
WHAT'S NEW IN COLORECTAL CANCER RESEARCH?
JUNE 20, 2012
8 - 9:30 PM EASTERN TIME
WHEN YOU'RE OUT OF OPTIONS
JULY 18, 2012
8 - 9:30 PM EASTERN TIME
REGISTER AT
WWW.FIGHTCOLORECTALCANCER.ORG
PRESENTATIONS MATERIAL AT:
HTTP://WWW.SLIDESHARE.NET/FIGHTCRC/